Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Medicine Regimen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01016054
What this trial is testing

The Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

Who this might be right for
CarcinomaOvarian CancerOvarian Diseases+1 more
Astellas Pharma Inc 4
Not applicableStudy completedNCT01902615
What this trial is testing

An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05226871
What this trial is testing

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

Who this might be right for
Breast CancerHead and Neck Cancer
Pfizer 35
Not applicableEnded earlyNCT03483987
What this trial is testing

Re-treatment of HCV Following DAA Failure

Who this might be right for
Chronic Hepatitis C
Sanjay Gandhi Postgraduate Institute of Medical Sciences 18
Testing effectiveness (Phase 2)Ended earlyNCT00076804
What this trial is testing

Helping HIV Infected Patients in South Africa Adhere to Drug Regimens

Who this might be right for
HIV Infections
Johns Hopkins University 274
Post-approval studies (Phase 4)Study completedNCT00515021
What this trial is testing

Diurnal Variation of Plasminogen Activator Inhibitor-1

Who this might be right for
Metabolic Syndrome X
Vanderbilt University Medical Center 21
Post-approval studies (Phase 4)UnknownNCT02117726
What this trial is testing

Impact of Various Sedation Regimens on the Incidence of Delirium

Who this might be right for
Delirium
Shandong Provincial Hospital 320
Not applicableStudy completedNCT00000896
What this trial is testing

Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT05284097
What this trial is testing

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Who this might be right for
Virus DiseasesHemorrhagic Fever, EbolaInfections+8 more
London School of Hygiene and Tropical Medicine 133
Early research (Phase 1)Study completedNCT03984097
What this trial is testing

Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma
Takeda 50
Early research (Phase 1)Study completedNCT00001091
What this trial is testing

Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Large-scale testing (Phase 3)UnknownNCT04979468
What this trial is testing

Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study)

Who this might be right for
HIV-1-infection
Societa' Italiana Di Malattie Infettive E Tropicali 440
Testing effectiveness (Phase 2)Looking for participantsNCT06611839
What this trial is testing

Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML

Who this might be right for
AMLIDH1 MutationTreatment
Institute of Hematology & Blood Diseases Hospital, China 23
Not applicableStudy completedNCT04915872
What this trial is testing

Are Standard Dosing Regimens of Piperacillin-Tazobactam Suitable in Critically Ill Patients With Open Abdomen and Negative Pressure Wound Therapy? A Population Pharmacokinetic Study.

Who this might be right for
LaparotomyCritical IllnessPiperacillin, Tazobactam Drug Combination
University Hospital, Bordeaux 46
Large-scale testing (Phase 3)Study completedNCT00000903
What this trial is testing

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 444
Large-scale testing (Phase 3)UnknownNCT04406727
What this trial is testing

UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection

Who this might be right for
HIV-1 Infection
United BioPharma 50
Testing effectiveness (Phase 2)Study completedNCT00002442
What this trial is testing

Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Looking for participantsNCT06907342
What this trial is testing

Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)

Who this might be right for
Tumor, ColorectalOrganoidsTumoroid+3 more
St. Olavs Hospital 148
Not applicableStudy completedNCT00073424
What this trial is testing

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Large-scale testing (Phase 3)Study completedNCT02707861
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 79
Next Page